Pinta: Guide To Stages, Diagnosis, Treatment, And Prevention
Chronic skin disease caused by Treponema carateum, endemic to Latin America, treatable with antibiotics but may cause permanent pigmentation changes.
Pinta, also known as carate, mal del pinto, or azul, is a chronic infectious skin disease caused by the spirochete bacterium Treponema carateum. It belongs to the group of endemic treponematoses, which includes yaws and bejel, but uniquely affects only the skin without systemic involvement. Endemic to rural, tropical regions of Central and South America, pinta manifests in three progressive stages: primary, secondary, and tertiary, characterized by evolving skin lesions from initial papules to widespread dyschromic patches. Transmission occurs via direct skin-to-skin contact, particularly in areas with poor hygiene, and is highly contagious in early stages. Although rare today due to antibiotic campaigns, cases persist in remote communities. Early treatment with penicillin eradicates the infection, but late-stage pigmentation changes are often irreversible.
What is pinta?
Pinta represents the mildest form of the non-venereal treponematoses, distinguished by its exclusive dermal tropism. Unlike syphilis (Treponema pallidum), which invades multiple organs, T. carateum remains confined to the skin’s dermis, producing no cardiovascular, neurological, or skeletal complications. First described in 16th-century Mexico, the disease derives its name from the Spanish word for ‘painted’ or ‘spotted,’ reflecting the multicolored lesions it produces. The World Health Organization recognizes pinta as a neglected tropical disease, with historical endemicity in 15 Latin American countries, though eradication efforts have reduced prevalence dramatically. The latest confirmed case was reported in Brazil in 2020. Primarily affecting children aged 5-15 in impoverished rural settings, pinta spreads through prolonged close contact, often within families or communities lacking sanitation. Insect vectors may facilitate transmission by breaking skin barriers. Serological tests cross-react with syphilis due to antigenic similarity, complicating diagnosis in non-endemic areas.
Who gets pinta?
Pinta predominantly impacts individuals in tropical rural areas of Mexico, Central America (e.g., Guatemala, Honduras), Colombia, Peru, Ecuador, and the Caribbean. It thrives in hot, humid environments with overcrowding and limited access to healthcare. Children and adolescents are most susceptible, accounting for over 90% of cases, as the disease enters through minor skin abrasions during play or work. Adults acquire it less frequently but can transmit unknowingly. Poor hygiene, malnutrition, and barefoot walking increase risk by providing entry points for spirochetes. Indigenous populations in remote villages bear the brunt, with historical seroprevalence exceeding 20% in some communities before mass treatment campaigns. Gender distribution is roughly equal, though males may present more due to outdoor labor exposure. Travelers to endemic zones are at negligible risk unless engaging in prolonged skin contact with locals.
What causes pinta?
The causative agent is Treponema carateum, a motile, spiral-shaped spirochete morphologically and serologically akin to T. pallidum subsp. pertenue (yaws) and T. pallidum subsp. endemicum (bejel). This bacterium invades the dermal layer via microtrauma, proliferating locally without hematogenous dissemination. Unlike sexually transmitted treponemes, pinta spreads non-sexually through direct contact with active lesions, especially if skin is abraded. Incubation averages 2-3 weeks, after which primary lesions emerge. The organism evades host immunity, persisting for years and driving chronic inflammation, hyperkeratosis, and pigmentary disturbances. Genetic analyses confirm T. carateum‘s unique niche adaptation to cutaneous tissue.
What are the clinical features of pinta?
Pinta progresses through three distinct stages over years if untreated, with lesions evolving in morphology, color, and distribution.
Primary stage
Following a 2-3 week incubation, a single erythematous papule (1-4 cm) appears on exposed sites like hands, feet, arms, legs, or face. It enlarges, becomes hyperkeratotic (scaly), and pruritic, sometimes ulcerating superficially. Regional lymphadenopathy occurs without fever or systemic signs. The lesion persists 3-6 months before healing spontaneously, often leaving faint pigmentation.
Secondary stage
3-22 months post-primary (average 6-9 months), disseminated ‘pintids’ erupt: smaller (0.5-2 cm), flattened plaques spreading across trunk, extremities, and face. Initial red-violet hues shift to brown, slate-blue, black, or gray, with central depigmentation. Lesions may coalesce into annular or geographic patterns, remaining infectious and symptomatic (itchy, painful). This phase lasts months to years, causing widespread involvement.
Tertiary (late) stage
Developing 2-5 years after onset, late lesions feature achromic (white) depigmented patches amid hyperpigmented areas, creating a mottled ‘leopard skin’ appearance. Skin atrophies (thins), wrinkles, or hyperkeratoses, especially on extensor surfaces and periarticular sites (hands, elbows, knees). These changes are permanent, nontender, and non-infectious, persisting lifelong despite treatment. No scarring or ulceration occurs.
Diagnosis
Diagnosis is primarily clinical, based on characteristic lesions in endemic exposure history. Dark-field microscopy of early lesion scrapings reveals spirochetes (highly sensitive in primary/secondary stages). Non-treponemal serology (RPR, VDRL) and treponemal tests (TPHA, FTA-ABS) are positive, mirroring syphilis but titers lower in late disease. Biopsy shows dermal treponemes, acanthosis, and pigment incontinence. Differential includes yaws, psoriasis, tinea versicolor, and post-kala-azar dermal leishmaniasis. PCR for T. carateum is investigational.
What is the treatment for pinta?
Benzathine penicillin G (1.2 million units IM, single dose) cures infection in all stages, halting progression and rendering noninfectious within 24 hours. Early treatment reverses primary/secondary lesions; tertiary pigmentary/atrophic changes persist. Alternatives for penicillin-allergic: doxycycline 100 mg PO BID x 14 days or tetracycline. Mass campaigns using penicillin eradicated pinta from many areas. Contact prophylaxis is recommended.
What is the outcome for pinta?
Untreated, pinta causes cosmetic disfigurement but no mortality or organ damage. Early therapy yields full resolution; late cases retain dyschromia (80-90% achromia irreversible). Recurrence is rare post-treatment. Cosmetic options like lasers address residual hypopigmentation. Public health surveillance sustains low incidence.
How can pinta be prevented?
Prevention hinges on early detection, antibiotic treatment of cases/contacts, and hygiene education. Avoid skin contact with lesions; cover abrasions. Community penicillin campaigns, as per WHO, eliminated pinta in many foci. Vector control (insecticides) may help. No vaccine exists.
Related topics
- Yaws
- Bejel
- Syphilis
- Treponematoses
- Neglected tropical diseases
Frequently asked questions
Is pinta contagious?
Yes, highly in primary/secondary stages via skin contact; late stage noninfectious.
Does pinta affect internal organs?
No, strictly cutaneous.
Can pinta be cured?
Yes, with one penicillin injection; early lesions heal fully.
Is pinta the same as syphilis?
No, different bacterium and transmission, though serologies cross-react.
Where is pinta found today?
Rarely in rural Latin America; last case Brazil 2020.
References
- Pinta | Treponema pallidum, Skin Lesions & Diagnosis — Britannica. 2023. https://www.britannica.com/science/pinta-pathology
- Pinta (Disease): Causes, Symptoms, Diagnosis & Treatment — Cleveland Clinic. 2023-10-25. https://my.clevelandclinic.org/health/diseases/25091-pinta
- Pinta: Latin America’s Forgotten Disease? — PubMed Central (PMC). 2016-01-01. https://pmc.ncbi.nlm.nih.gov/articles/PMC4703279/
- Pinta (disease) — Wikipedia (primary sources referenced). 2023. https://en.wikipedia.org/wiki/Pinta_(disease)
- Pinta – Symptoms, Causes, Treatment — National Organization for Rare Disorders (NORD). 2023. https://rarediseases.org/rare-diseases/pinta/
Similar Articles
Read full bio of Sneha Tete
